Skip to main content
Candel Therapeutics, Inc. logo

Candel Therapeutics, Inc. — Investor Relations & Filings

Ticker · CADL ISIN · US1374041093 US Manufacturing
Open in API
Filings indexed 368 across all filing types
Latest filing 2021-07-30 Director's Dealing
Country US United States of America
Listing US CADL

About Candel Therapeutics, Inc.

https://www.candeltx.com/

Candel Therapeutics, Inc. is a company developing viral immunotherapies designed to activate a patient's immune system to fight cancer. Its approach utilizes two main platforms based on engineered adenovirus and Herpes Simplex Virus (HSV). These investigational, off-the-shelf therapies are administered directly into tumors to induce immunogenic cell death. This process is intended to stimulate a personalized, systemic, and durable anti-tumor response specific to the individual's cancer. The company aims to create treatments that are both efficacious and well-tolerated for patients across various disease stages.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2021-07-30 English
8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated July 29, 2021, by Candel Therapeutics, Inc. The content includes announcements of the appointment of a new director to the board and amendments to the company's certificate of incorporation and bylaws. There are no financial statements or detailed financial data presented. The primary focus is on changes in the board of directors and corporate governance documents. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document length is 6961 characters, which is sufficient to contain substantive information, and it is not merely an announcement of a report publication. Therefore, the appropriate classification is MANG with high confidence.
2021-07-29 English
S-8
Share Issue/Capital Change Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used for registering securities to be offered under employee benefit plans such as stock option plans and employee stock purchase plans. It includes detailed information about the plans, the number of shares to be registered, and legal provisions related to indemnification of directors and officers. This type of filing is related to share issuance under employee plans and is not a financial report, earnings release, or management discussion. It is specifically a registration statement for securities issuance under employee benefit plans, which corresponds to announcements regarding new share issues or capital changes. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length and content confirm it is the actual registration statement, not just an announcement or a certification, so SHA is the correct category with high confidence.
2021-07-29 English
424B4
Capital/Financing Update Classification · 95% confidence The document is a detailed prospectus for an initial public offering (IPO) of common stock, including extensive information about the offering, company overview, risk factors, financial data, management discussion, and other disclosures typical of a registration statement filed with the SEC. The presence of the term 'prospectus' and the detailed offering information indicates this is a capital raising document. It is not an annual report, earnings release, or any other report type but a registration/prospectus document related to capital markets activity. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is not a brief announcement or a regulatory filing fallback.
2021-07-28 English
Regulatory Filings 2021
Regulatory Filings
2021-07-27 English
FORM 3 SUBMISSION
Director's Dealing
2021-07-27 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.